Begin main content

Reports

We found 6669 result(s)

apomorphine hydrochloride (Kynmobi)

Last Updated: January 23, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: apomorphine hydrochloride
Indications: Parkinson’s Disease

  • Brand Name: Kynmobi
  • Manufacturer: Sunovion Pharmaceuticals Canada Inc.
  • Project Number: SR0604-000
  • Project Status: Withdrawn
  • Submission Type: New

Iron (III) Isomaltoside 1000 (Monoferric)

Last Updated: January 23, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: Iron (III) Isomaltoside 1000
Indications: iron deficiency anemia

  • Brand Name: Monoferric
  • Manufacturer: Pharmacosmos A/S
  • Project Number: SR0622-000
  • Project Status: Active
  • Submission Type: New

tafamidis (Vyndaqel)

Last Updated: January 23, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: tafamidis
Indications: transthyretin-mediated amyloidosis

  • Brand Name: Vyndaqel
  • Manufacturer: Pfizer Canada
  • Project Number: SR0625-000
  • Project Status: Active
  • Submission Type: New

glycopyrrolate (Cuvposa)

Last Updated: January 23, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: glycopyrrolate
Indications: chronic severe drooling, neurologic (pediatric)

  • Brand Name: Cuvposa
  • Manufacturer: MEDEXUS Pharmaceuticals, Inc.
  • Project Number: SR0613-000
  • Project Status: Active
  • Submission Type: New

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy: A Critical Appraisal of the MENTOR Study

Last Updated: January 23, 2020
Result type: Reports
Product Line: Technology Review

Membranous nephropathy is an autoimmune disease that commonly presents as nephrotic syndrome. The current guideline recommends treating this condition with cyclophosphamide and corticosteroids. Alternatively, cyclosporine or tacrolimus may be used. The MENTOR study, published in July 2019, compared rituximab with cyclosporine in inducing and ma...

  • Project Number: HA0001-000

Pharmaceutical Advisory Committee (PAC)

Published on: January 23, 2020
Result type: General Content

The Pharmaceutical Advisory Committee (PAC) comprises representatives from the federal, provincial, and territorial publicly funded drug plans and other related health organizations. PAC provides strategic advice on drug policy issues, including cancer-specific issues and drug topics, to CADTH and its Board. Committee members also facilitate the...

vortioxetine hydrobromide (Trintellix )

Last Updated: January 22, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: vortioxetine hydrobromide
Indications: Major depressive disorder (MDD), adults.

  • Brand Name: Trintellix
  • Manufacturer: Lundbeck Canada Inc.
  • Project Number: SR0611-000
  • Project Status: Active
  • Submission Type: New

icosapent ethyl (Vascepa)

Last Updated: January 22, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: icosapent ethyl
Indications: Ischemic events in statin-treated patients

  • Brand Name: Vascepa
  • Manufacturer: HLS Therapeutics
  • Project Number: SR0619-000
  • Project Status: Active
  • Submission Type: New